Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1983 Nov;59(697):677–689. doi: 10.1136/pgmj.59.697.677

Familial venous thrombosis.

J H Winter, A S Douglas
PMCID: PMC2417670  PMID: 6359104

Full text

PDF
677

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Mondhiry H., Bilezikian S. B., Nossel H. L. Fibrinogen ""New York"--an abnormal fibrinogen associated with thromboembolism: functional evaluation. Blood. 1975 May;45(5):607–619. [PubMed] [Google Scholar]
  2. Ambruso D. R., Jacobson L. J., Hathaway W. E. Inherited antithrombin III deficiency and cerebral thrombosis in a child. Pediatrics. 1980 Jan;65(1):125–131. [PubMed] [Google Scholar]
  3. Aoki N., Moroi M., Sakata Y., Yoshida N., Matsuda M. Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest. 1978 May;61(5):1186–1195. doi: 10.1172/JCI109034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beck E. A., Charache P., Jackson D. P. A new inherited coagulation disorder caused by an abnormal fibrinogen ('fibrinogen Baltimore'). Nature. 1965 Oct 9;208(5006):143–145. doi: 10.1038/208143a0. [DOI] [PubMed] [Google Scholar]
  5. Bertina R. M., Broekmans A. W., van der Linden I. K., Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemost. 1982 Aug 24;48(1):1–5. [PubMed] [Google Scholar]
  6. Bessot J. C., Quoix E., Charbonneau J., Burghard G., Wiesel M. L., Kalogjera N., Mayer S., Mayer G. Déficit héréditaire en anti-thrombine III responsable d'accidents thrombo-emboliques récidivants. Nouv Presse Med. 1978 Mar 25;7(12):999–1002. [PubMed] [Google Scholar]
  7. Beukes C. A., Heyns A. D. A South African family with antithrombin III deficiency. S Afr Med J. 1980 Sep 27;58(13):528–530. [PubMed] [Google Scholar]
  8. Boyer C., Wolf M., Lavergne J. M., Larrieu M. J. Thrombin generation and formation of thrombin-antithrombin III complexes in congenital antithrombin III deficiency. Thromb Res. 1980 Oct 15;20(2):207–218. doi: 10.1016/0049-3848(80)90386-2. [DOI] [PubMed] [Google Scholar]
  9. Brandt P., Stenbjerg S. Subcutaneous heparin for thrombosis in pregnant women with hereditary antithrombin deficiency. Lancet. 1979 Jan;1(8107):100–101. doi: 10.1016/s0140-6736(79)90084-9. [DOI] [PubMed] [Google Scholar]
  10. Brozovic M., Stirling Y., Hamlyn A. N. Thrombotic tendency and probable antithrombin III deficiency. Thromb Haemost. 1978 Jun 30;39(3):778–779. [PubMed] [Google Scholar]
  11. Bull H., Mackie I., Brozović M., Woodings D. Antithrombin III in patients on long-term oral anticoagulants. J Clin Pathol. 1980 Dec;33(12):1202–1205. doi: 10.1136/jcp.33.12.1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Burrowes C. E., Habal F. M., Movat H. Z. The inhibition of human plasma kallikrein by antithrombin III. Thromb Res. 1975 Jul;7(1):175–183. doi: 10.1016/0049-3848(75)90134-6. [DOI] [PubMed] [Google Scholar]
  13. Caillé J. P., Sarrade-Loucheur C., Ferrer F., Vergoz D. Phlébites récidivantes familiales par déficit en antithrombine III. A propos d'un cas. Phlebologie. 1980 Jan-Mar;33(1):131–137. [PubMed] [Google Scholar]
  14. Carvalho A., Ellman L. Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function. Am J Med. 1976 Aug;61(2):179–183. doi: 10.1016/0002-9343(76)90167-4. [DOI] [PubMed] [Google Scholar]
  15. Chan V., Chan T. K., Wong V., Tso S. C., Todd D. The determination of antithrombin III by radioimmunoassay and its clinical application. Br J Haematol. 1979 Apr;41(4):563–572. doi: 10.1111/j.1365-2141.1979.tb05893.x. [DOI] [PubMed] [Google Scholar]
  16. Clemmensen I. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin. Thromb Haemost. 1978 Jun 30;39(3):616–623. [PubMed] [Google Scholar]
  17. DAVIE E. W., RATNOFF O. D. WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. Science. 1964 Sep 18;145(3638):1310–1312. doi: 10.1126/science.145.3638.1310. [DOI] [PubMed] [Google Scholar]
  18. Davidson J. F., Lochhead M., McDonald G. A., McNicol G. P. Fibrinolytic enhancement by stanozolol: a double blind trial. Br J Haematol. 1972 May;22(5):543–559. [PubMed] [Google Scholar]
  19. Dyerberg J., Stoffersen E. Recurrent thrombosis in a patient with factor XII deficiency. Acta Haematol. 1980;63(5):278–282. doi: 10.1159/000207416. [DOI] [PubMed] [Google Scholar]
  20. EGEBERG O. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh. 1965 Jun 15;13:516–530. [PubMed] [Google Scholar]
  21. Egeberg O. Inherited fibrinogen abnormality causing thrombophilia. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):176–187. [PubMed] [Google Scholar]
  22. Fagerhol M. K., Abildgaard U., Bergsjo P., Jacobsen J. H. Oral contraceptives and low antithrombin-3 concentration. Lancet. 1970 May 30;1(7657):1175–1175. doi: 10.1016/s0140-6736(70)91248-1. [DOI] [PubMed] [Google Scholar]
  23. Fiessinger J. N., Aiach M. Stanazolol treatment in an AT III deficient patient. Thromb Haemost. 1980 Jun 18;43(2):183–183. [PubMed] [Google Scholar]
  24. Filip D. J., Eckstein J. D., Veltkamp J. J. Hereditary antithrombin III deficiency and thromboembolic disease. Am J Hematol. 1976;1(3):343–349. doi: 10.1002/ajh.2830010310. [DOI] [PubMed] [Google Scholar]
  25. Fish W. W., Björk I. Release of a two-chain form of antithrombin from the antithrombin-thrombin complex. Eur J Biochem. 1979 Nov 1;101(1):31–38. doi: 10.1111/j.1432-1033.1979.tb04212.x. [DOI] [PubMed] [Google Scholar]
  26. Frost T., Loveday D. Oral anticoagulants and antithrombin III. Med J Aust. 1980 Aug 23;2(4):220–220. [PubMed] [Google Scholar]
  27. Gaston L. W. Studies on a family with an elevated plasma level of factor V (proaccelerin) and a tendency to thrombosis. J Pediatr. 1966 Mar;68(3):367–373. doi: 10.1016/s0022-3476(66)80239-1. [DOI] [PubMed] [Google Scholar]
  28. Griffin J. H., Evatt B., Zimmerman T. S., Kleiss A. J., Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981 Nov;68(5):1370–1373. doi: 10.1172/JCI110385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gruenberg J. C., Smallridge R. C., Rosenberg R. D. Inherited antithrombin-III deficiency causing mesenteric venous infarction: a new clinical entity. Ann Surg. 1975 Jun;181(6):791–794. doi: 10.1097/00000658-197506000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gyde O. H., Middleton M. D., Vaughan G. R., Fletcher D. J. Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses. Br Med J. 1978 Mar 11;1(6113):621–622. doi: 10.1136/bmj.1.6113.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hall J. G., Pauli R. M., Wilson K. M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980 Jan;68(1):122–140. doi: 10.1016/0002-9343(80)90181-3. [DOI] [PubMed] [Google Scholar]
  32. Harker L. A., Ross R., Slichter S. J., Scott C. R. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976 Sep;58(3):731–741. doi: 10.1172/JCI108520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hellgren M., Tengborn L., Abildgaard U. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet Invest. 1982;14(2):127–141. doi: 10.1159/000299460. [DOI] [PubMed] [Google Scholar]
  34. Highsmith R. F., Rosenberg R. D. The inhibition of human plasmin by human antithrombin-heparin cofactor. J Biol Chem. 1974 Jul 25;249(14):4335–4338. [PubMed] [Google Scholar]
  35. Hofman K. J., Goldman A. P., Lurie M., Hockly J., Bradlow B. A. Familial thrombosis associated with antithrombin III deficiency in a young adult male. A case report. S Afr Med J. 1980 Sep 27;58(13):531–533. [PubMed] [Google Scholar]
  36. Holmer E., Söderström G., Andersson L. O. Properties of antithrombin III depleted plasma. I. Effect of heparin. Thromb Res. 1980 Jan 1;17(1-2):113–124. doi: 10.1016/0049-3848(80)90299-6. [DOI] [PubMed] [Google Scholar]
  37. Hule V. Vrozené rodinné snízení antitrombinu III. Vnitr Lek. 1977 Sep;23(9):887–892. [PubMed] [Google Scholar]
  38. Isacson S., Nilsson I. M. Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. Acta Chir Scand. 1972;138(4):313–319. [PubMed] [Google Scholar]
  39. Johansson L., Hedner U., Nilsson I. M. A family with thromboembolic disease associated with deficient fibrinolytic activity in vessel wall. Acta Med Scand. 1978;203(6):477–480. doi: 10.1111/j.0954-6820.1978.tb14911.x. [DOI] [PubMed] [Google Scholar]
  40. Johansson L., Hedner U., Nilsson I. M. Familial antithrombin III deficiency as pathogenesis of deep venous thrombosis. Acta Med Scand. 1978;204(6):491–495. doi: 10.1111/j.0954-6820.1978.tb08478.x. [DOI] [PubMed] [Google Scholar]
  41. Juillet Y., Aiach M., Fiessinger J. N., Leclerc M., Housset E. Antithrombine III et thromboses veineuses. Sem Hop. 1978 Nov 8;54(37-40):1126–1129. [PubMed] [Google Scholar]
  42. Kisiel W. Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest. 1979 Sep;64(3):761–769. doi: 10.1172/JCI109521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Laharrague P., Biermé R., Cérène A., Boucays A., Massip P. Antithrombin III: substitutive treatment of the hereditary deficiency. Thromb Haemost. 1980 Feb 29;43(1):72–72. [PubMed] [Google Scholar]
  44. Leone G., Valori V. M., Storti S., Myers T. J. Inferior vena cava thrombosis in a child with familial antithrombin III deficiency. Thromb Haemost. 1980 Feb 29;43(1):74–74. [PubMed] [Google Scholar]
  45. Longy M., Delmas M., Leman C., Le Bras M., Moretti G., Hourdille P. Thrombose de la veine cave inférieure avec déficit congénital en antithrombine III. Nouv Presse Med. 1980 Jun 28;9(28):1957–1958. [PubMed] [Google Scholar]
  46. Mackie M., Bennett B., Ogston D., Douglas A. S. Familial thrombosis: inherited deficiency of antithrombin III. Br Med J. 1978 Jan 21;1(6106):136–138. doi: 10.1136/bmj.1.6106.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Marciniak E., Farley C. H., DeSimone P. A. Familial thrombosis due to antithrombin 3 deficiency. Blood. 1974 Feb;43(2):219–231. [PubMed] [Google Scholar]
  48. Marciniak E., Gockerman J. P. Heparin-induced decrease in circulating antithrombin-III. Lancet. 1977 Sep 17;2(8038):581–584. doi: 10.1016/s0140-6736(77)91429-5. [DOI] [PubMed] [Google Scholar]
  49. Marlar R. A., Kleiss A. J., Griffin J. H. Human protein C: inactivation of factors V and VIII in plasma by the activated molecule. Ann N Y Acad Sci. 1981;370:303–310. doi: 10.1111/j.1749-6632.1981.tb29743.x. [DOI] [PubMed] [Google Scholar]
  50. Matsuo T., Ohki Y., Kondo S., Matsuo O. Familial antithrombin III deficiency in a Japanese family. Thromb Res. 1979;16(5-6):815–823. doi: 10.1016/0049-3848(79)90224-x. [DOI] [PubMed] [Google Scholar]
  51. McKay E. J. Immunochemical analysis of active and inactive antithrombin III. Br J Haematol. 1980 Oct;46(2):277–285. doi: 10.1111/j.1365-2141.1980.tb05967.x. [DOI] [PubMed] [Google Scholar]
  52. Meade T. W., North W. R., Chakrabarti R., Haines A. P., Stirling Y. Population-based distributions of haemostatic variables. Br Med Bull. 1977 Sep;33(3):283–288. doi: 10.1093/oxfordjournals.bmb.a071448. [DOI] [PubMed] [Google Scholar]
  53. Nagy I., Losonczy H., Szaksz I., Temesi C., Hergert K. An analysis of clinical and laboratory data in patients with congenital antithrombin III (AT III) deficiency. Acta Med Acad Sci Hung. 1979;36(1):53–60. [PubMed] [Google Scholar]
  54. Nordenman B., Nyström C., Björk I. The size and shape of human and bovine antithrombin III. Eur J Biochem. 1977 Aug 15;78(1):195–203. doi: 10.1111/j.1432-1033.1977.tb11730.x. [DOI] [PubMed] [Google Scholar]
  55. Osterud B., Miller-Andersson M., Abildgaard U., Prydz H. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X. Thromb Haemost. 1976 Apr 30;35(2):295–304. [PubMed] [Google Scholar]
  56. Owen W. G., Penick G. D., Yoder E., Poole B. L. Evidence for an ester bond between thrombin and heparin cofactor. Thromb Haemost. 1976 Feb 29;35(1):87–95. [PubMed] [Google Scholar]
  57. Penick G. D., Dejanov I. I., Reddick R. L., Roberts H. R. Predisposition to intravascular coagulation. Thromb Diath Haemorrh Suppl. 1966;21:543–554. [PubMed] [Google Scholar]
  58. Pitney W. R., Manoharan A., Dean S. Antithrombin III deficiency in an Australian family. Br J Haematol. 1980 Sep;46(1):147–149. doi: 10.1111/j.1365-2141.1980.tb05947.x. [DOI] [PubMed] [Google Scholar]
  59. Refvem O., Fagerhol M. K., Abildgaard U. Changes in antithrombin 3 levels following cessation of anticoagulant therapy. Acta Med Scand. 1973 Apr;193(4):307–309. doi: 10.1111/j.0954-6820.1973.tb10582.x. [DOI] [PubMed] [Google Scholar]
  60. Rey J. L., Delobel J., Claisse J. F., Quiret J. C., Bor P., Bernasconi P. Embolie pulmonaire sévère et thrombophlébite récidivante en rapport avec un déficit héréditaire en antithrombine III. Arch Mal Coeur Vaiss. 1979 Aug;72(8):919–923. [PubMed] [Google Scholar]
  61. Rosenberg R. D., Damus P. S. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem. 1973 Sep 25;248(18):6490–6505. [PubMed] [Google Scholar]
  62. Rosenberg R. D. The effect of heparin on factor XIa and plasmin. Thromb Diath Haemorrh. 1975 Feb 28;33(1):51–62. [PubMed] [Google Scholar]
  63. Rubinowitz M. J., Ford C. Familial antithrombin III deficiency. An important clinical entity. Rocky Mt Med J. 1977 Sep-Oct;74(5):246–249. [PubMed] [Google Scholar]
  64. Saito H., Ratnoff O. D., Donaldson V. H. Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma. Circ Res. 1974 May;34(5):641–651. doi: 10.1161/01.res.34.5.641. [DOI] [PubMed] [Google Scholar]
  65. Sas G., Blaskó G., Bánhegyi D., Jákó J., Pálos L. A. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia. Thromb Diath Haemorrh. 1974 Sep 30;32(1):105–115. [PubMed] [Google Scholar]
  66. Sas G., Pepper D. S., Cash J. D. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest. Thromb Diath Haemorrh. 1975 Jun 30;33(3):564–572. [PubMed] [Google Scholar]
  67. Sas G., Petö I., Bánhegyi D., Blaskó G., Domján G. Heterogeneity of the "classical" antithrombin III deficiency. Thromb Haemost. 1980 Jun 18;43(2):133–136. [PubMed] [Google Scholar]
  68. Scully M. F., De Haas H., Chan P., Kakkar V. V. Hereditary antithrombin III deficiency in an English family. Br J Haematol. 1981 Feb;47(2):235–240. doi: 10.1111/j.1365-2141.1981.tb02784.x. [DOI] [PubMed] [Google Scholar]
  69. Stathakis N. E., Papayannis A. G., Antonopoulos M., Gardikas C. Familial thrombosis due to antithrombin III deficiency in a Greek family. Acta Haematol. 1977;57(1):47–54. doi: 10.1159/000207859. [DOI] [PubMed] [Google Scholar]
  70. Stead N. W., Bauer K. A., Kinney T. R., Lewis J. G., Campbell E. E., Shifman M. A., Rosenberg R. D., Pizzo S. V. Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor. Am J Med. 1983 Jan;74(1):33–39. doi: 10.1016/0002-9343(83)91115-4. [DOI] [PubMed] [Google Scholar]
  71. Stead N., Kaplan A. P., Rosenberg R. D. Inhibition of activated factor XII by antithrombin-heparin cofactor. J Biol Chem. 1976 Nov 10;251(21):6481–6488. [PubMed] [Google Scholar]
  72. Stenflo J. A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization. J Biol Chem. 1976 Jan 25;251(2):355–363. [PubMed] [Google Scholar]
  73. Sørensen P. J., Dyerberg J., Stoffersen E., Jensen M. K. Familial functional antithrombin III deficiency. Scand J Haematol. 1980 Feb;24(2):105–109. doi: 10.1111/j.1600-0609.1980.tb02352.x. [DOI] [PubMed] [Google Scholar]
  74. Thaler E., Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol. 1981 Jun;10(2):369–390. [PubMed] [Google Scholar]
  75. Thuot C., Marion D., Boucher H. Déficit congénital en antithrombine III: etude d'une famille québécoise. Union Med Can. 1977 May;106(5):673–677. [PubMed] [Google Scholar]
  76. Tran T. H., Bounameaux H., Bondeli C., Honkanen H., Marbet G. A., Duckert F. Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis. Thromb Haemost. 1980 Oct 31;44(2):87–91. [PubMed] [Google Scholar]
  77. Tripodi A., Boyer C., Canciani M. T., D'Angelo A., Mannucci P. M. Inherited deficiency of antithrombin III in an Italian kindred. Ric Clin Lab. 1980 Jul-Sep;10(3):521–529. doi: 10.1007/BF02938798. [DOI] [PubMed] [Google Scholar]
  78. Walker I. D., Davidson J. F., Young P., Conkie J. A. Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels. Thromb Diath Haemorrh. 1975 Sep 30;34(1):106–114. [PubMed] [Google Scholar]
  79. Wessler S., Gitel S. N., Bank H., Martinowitz U., Stephenson R. C. An assay of the antithrombotic action of warfarin: its correlation with the inhibition of stasis thrombosis in rabbits. Thromb Haemost. 1979 Feb 15;40(3):486–498. [PubMed] [Google Scholar]
  80. Winter J. H., Bennett B., McTaggart F., Douglas A. S. Lipoprotein fractions and antithrombin III consumption during clotting. Thromb Haemost. 1982 Jun 28;47(3):236–238. [PubMed] [Google Scholar]
  81. Winter J. H., Fenech A., Bennett B., Douglas A. S. Thrombosis after venography in familial antithrombin II deficiency. Br Med J (Clin Res Ed) 1981 Nov 28;283(6304):1436–1437. doi: 10.1136/bmj.283.6304.1436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Winter J., Donald D., Bennett B., Douglas A. S. Arterial thrombosis and accelerated atheroma in a member of a family with familial antithrombin III deficiency. Postgrad Med J. 1982 Feb;58(676):108–109. doi: 10.1136/pgmj.58.676.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Wohl R. C., Summaria L., Robbins K. C. Physiological activation of the human fibrinolytic system. Isolation and characterization of human plasminogen variants, Chicago I and Chicago II. J Biol Chem. 1979 Sep 25;254(18):9063–9069. [PubMed] [Google Scholar]
  84. Zucker M. L., Gomperts E. D., Marcus R. G. Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency. S Afr Med J. 1976 Oct 9;50(43):1743–1748. [PubMed] [Google Scholar]
  85. van der Meer J., Stoepman-van Dalen E. A., Jansen J. M. Antithrombin-3 deficiency in a Dutch family. J Clin Pathol. 1973 Jul;26(7):532–538. doi: 10.1136/jcp.26.7.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. von Kaulla E., von Kaulla K. N. Deficiency of antithrombin 3 activity associated with hereditary thrombosis tendency. J Med. 1972;3(6):349–358. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES